{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:57:50Z","timestamp":1789091870670,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1053\/j.ajkd.2016.08.018","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T13:26:02Z","timestamp":1475933162000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1053","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-3416","authenticated-orcid":false,"given":"Swapnil","family":"Hiremath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 suppl 1","key":"10.1053\/j.ajkd.2016.08.018_bib1","first-page":"S1","article-title":"US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States","volume":"67","author":"Saran","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2016.08.018_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1600-6143.2003.00315.x","article-title":"The burden of chronic kidney disease in renal transplant recipients","volume":"4","author":"Karthikeyan","year":"2004","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2016.08.018_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.ajkd.2009.06.031","article-title":"Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management","volume":"54","author":"Knoll","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2016.08.018_bib4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1053\/j.ajkd.2016.08.018_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2016.08.018_bib6","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1111\/ajt.13384","article-title":"Effect of ramipril on urinary protein excretion in maintenance renal transplant patients converted to sirolimus","volume":"15","author":"Mandelbrot","year":"2015","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2016.08.018_bib7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2016.08.018_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2016.08.018_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.TP.0000437672.78716.28","article-title":"Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers","volume":"97","author":"Opelz","year":"2014","journal-title":"Transplantation"},{"issue":"11","key":"10.1053\/j.ajkd.2016.08.018_bib10","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a Collaborative Transplant Study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2016.08.018_bib11","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2016.08.018_bib12","first-page":"CD003598","article-title":"Antihypertensive treatment for kidney transplant recipients","volume":"3","author":"Cross","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.ajkd.2016.08.018_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1681\/ASN.2012080777","article-title":"Angiotensin II blockade in kidney transplant recipients","volume":"24","author":"Ibrahim","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2016.08.018_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","author":"Knoll","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1053\/j.ajkd.2016.08.018_bib15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfp581","article-title":"Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET","volume":"25","author":"Philipp","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2016.08.018_bib16","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1053\/j.ajkd.2016.08.018_bib17","first-page":"38","article-title":"Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials","volume":"25","author":"Dickersin","year":"2002","journal-title":"Eval Health Prof"},{"key":"10.1053\/j.ajkd.2016.08.018_bib18","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1053\/j.ajkd.2016.08.018_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"3-4","key":"10.1053\/j.ajkd.2016.08.018_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples","volume":"37","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"issue":"7414","key":"10.1053\/j.ajkd.2016.08.018_bib21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.ajkd.2016.08.018_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1053\/j.ajkd.2016.08.018_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"7109","key":"10.1053\/j.ajkd.2016.08.018_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1053\/j.ajkd.2016.08.018_bib25","first-page":"1","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Byron","year":"2012","journal-title":"J\u00a0Stat Software"},{"issue":"1","key":"10.1053\/j.ajkd.2016.08.018_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/TP.0b013e3181bf13d9","article-title":"Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy","volume":"89","author":"Amara","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.ajkd.2016.08.018_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1034\/j.1399-0012.2001.150611.x","article-title":"Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial","volume":"15","author":"Midtvedt","year":"2001","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2016.08.018_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/TP.0b013e3182827a43","article-title":"Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial","volume":"95","author":"Paoletti","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2016.08.018_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000357205","article-title":"Specific management of anemia and hypertension in renal transplant recipients: influence of renin-angiotensin system blockade","volume":"39","author":"Salzberg","year":"2014","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.08.018_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1345\/aph.1K471","article-title":"Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation","volume":"42","author":"Jennings","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1053\/j.ajkd.2016.08.018_bib31","first-page":"549","article-title":"The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"31","author":"Daskalopoulou","year":"2015","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1053\/j.ajkd.2016.08.018_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2016.08.018_bib33","doi-asserted-by":"crossref","first-page":"i438","DOI":"10.1136\/bmj.i438","article-title":"Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials","volume":"352","author":"Bangalore","year":"2016","journal-title":"BMJ"},{"issue":"9982","key":"10.1053\/j.ajkd.2016.08.018_bib34","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2016.08.018_bib35","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2016.08.018_bib36","unstructured":"University of California San Francisco. Sample size calculators for designing clinical research. 2016. http:\/\/www.sample-size.net\/sample-size-proportions\/. Accessed June 18,\u00a02016."}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616304206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616304206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:58:25Z","timestamp":1759460305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616304206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0272638616304206"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.08.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735060024.793556272","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}